Latest Asx News

GTI Energy’s recent scoping study highlights promising economics for its Lo Herma uranium project in Wyoming, prompting plans for expanded drilling in 2025 to upgrade and grow its resource base.

Syntara Limited’s lead drug candidate SNT-5505 has secured FDA Fast Track designation, expediting its development for treating myelofibrosis, a rare and serious blood cancer with limited therapies.

Golden Horse Minerals has reported exceptional deep drilling results at its Hopes Hill project, revealing a significant high-grade gold intercept well below the historic pit floor and confirming a large mineralised system. Plans are underway to accelerate drilling and expand exploration efforts.

Theta Gold Mines has landed a US$35 million loan from South Africa’s Industrial Development Corporation, marking a key funding milestone for its TGME Underground Gold Mine Project.

Pure Foods Tasmania has raised $100,000 through a share placement and appointed directors to new operational roles aimed at driving sales growth and improving cost efficiency.

AnteoTech Ltd has completed a strategic review that refocuses its business on commercialising existing products, delivering $1.6 million in annual cost savings and expanding its sales pipeline in battery and life sciences markets.

Opyl Limited unveils a bold strategic pivot to enhance its AI-driven drug discovery platform, leveraging a vast proprietary dataset and leadership upgrades to redefine clinical trial innovation.

Yojee Limited and SmartClear have completed technical verification of their MOSAIC platform, a next-generation freight forwarding and customs messaging solution compliant with Australian and New Zealand customs regulations. This milestone sets the stage for a strategic partnership aimed at transforming logistics technology in the region.

Sunshine Metals has reported further shallow, high-grade gold intersections at its Liontown prospect, advancing plans for a resource upgrade and mining studies. The latest drilling results reinforce the company’s strategy to rapidly develop oxide gold resources near surface.

Argenica Therapeutics faces a clinical hold from the US FDA on its stroke drug trial application, though its Australian Phase 2 study remains unaffected and on track.

Stavely Minerals has launched a new drilling campaign at its Fairview North gold prospect, aiming to validate a major mineralised trend linking gold and copper-silver deposits in western Victoria.

Botanix Pharmaceuticals has secured a US$30 million debt facility from Kreos Capital, bolstering its financial position to commercialize Sofdra™ and pursue platform expansion opportunities.